compounded semaglutide fda warning november 2025 Drug Recalls and Warnings: Illegal GLP-1 Sales and Misleading Marketing by Novo Nordisk and Eli Lilly Compounded "semaglutide" is not FDA-approved

Pharmaceutical companies are charging Americans 10 times what they do in other countries

Not all metabolic surgeries are the same

This pattern fits with a medication that clears slowly and whose effects wane step by step

Retatrutide is in Phase 3 clinical trials traditionally one of the final steps before the FDA reviews and potentially approves a drug

Based on what we didnt hear, that suggests to me that theres a lot that the administration itself hasnt even ironed out as of yet. It just feels, she added, a little bit too squishy right now. The announcement marks one of the most ambitious efforts yet to tackle the high cost of weight loss drugs in the U.S